Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients

被引:13
作者
Ottevanger, PB
De Mulder, PHM
Grol, RPTM
van Lier, H
Beex, LVAM
机构
[1] Univ Nijmegen, Med Ctr, Dept Med, Div Med Oncol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Ctr Qual Care Res, Nijmegen, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Med Stat, Nijmegen, Netherlands
关键词
guideline implementation; breast cancer; quality improvement; indicators;
D O I
10.1016/S0959-8049(03)00660-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Guidelines are tools to improve the quality of care in daily practice. To accomplish adherence, active implementation is needed. The effect of audit, group-oriented feedback and educational activities to increase guideline adherence were investigated in this study. Treatment according to a guideline for premenopausal node-positive breast cancer patients from 1988 to 1992 (PI) and from 1996 to 1998 (P2) was assessed using the following indicators: percentage of patients with breast-conserving surgery, secondary surgery, greater than or equal to10 reported resected axillary lymph nodes, reported tumour differentiation grade, reported hormonal receptor status, chemotherapy received (CT), start of CT less than or equal to28 days after surgery, Dose Intensity (DI) greater than or equal to85% and completion of CT less than or equal to1 week beyond the ideal duration of CT. Data were audited from patients' records. The first audit resulted in a quality programme with feedback focused on the delivery of chemotherapy and resected axillary lymph nodes and educational sessions. A Fisher's exact test was used to estimate significant differences between the two time periods. In PI, 323 patients and in P2, 155 patients were eligible for treatment according to the guideline. The percentage of patients with greater than or equal to10 lymph nodes improved from 65.3 to 81.3% (P=0.0004), as did the percentage with a reported oestrogen receptor (ER) status, from 84.8 to 96.8% (P=0.00004), progesterone receptor (PR) status from 82.3% to 97.4% (P<0.000001) and with a DI greater than or equal to85%, from 74.9 to 93.9% (P=0.000003). Adherence varied between the hospitals. In conclusion, significant improvements were observed for the indicators of resected axillary lymph nodes and DI of chemotherapy, which may be attributed to the quality programme. Repeated assessment of the adherence to the guideline is important to observe changes and interhospital variations in order to remain focused on areas for improvement. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 15 条
[1]   CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].
BONADONNA, G ;
VALAGUSSA, P ;
MOLITERNI, A ;
ZAMBETTI, M ;
BRAMBILLA, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906
[2]   DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :10-15
[3]   Development of clinical guidelines [J].
Fletcher, SW ;
Fletcher, RH .
LANCET, 1998, 352 (9144) :1876-1876
[4]   EVALUATING THE MESSAGE - THE RELATIONSHIP BETWEEN COMPLIANCE RATE AND THE SUBJECT OF A PRACTICE GUIDELINE [J].
GRILLI, R ;
LOMAS, J .
MEDICAL CARE, 1994, 32 (03) :202-213
[5]   EFFECT OF CLINICAL GUIDELINES ON MEDICAL-PRACTICE - A SYSTEMATIC REVIEW OF RIGOROUS EVALUATIONS [J].
GRIMSHAW, JM ;
RUSSELL, IT .
LANCET, 1993, 342 (8883) :1317-1322
[6]   Attributes of clinical guidelines that influence use of guidelines in general practice: observational study [J].
Grol, R ;
Dalhuijsen, J ;
Thomas, S ;
in't Veld, C ;
Rutten, G ;
Mokkink, H .
BRITISH MEDICAL JOURNAL, 1998, 317 (7162) :858-861
[7]   An outcomes management program in gynecologic oncology [J].
Morris, M ;
Levenback, C ;
Burke, TW ;
Dejesus, Y ;
Lucas, KR ;
Gershenson, DM .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (04) :485-492
[8]   Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study [J].
Ottevanger, PB ;
Beex, LVAM .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) :386-391
[9]  
Ottevanger PB, 2002, ANTICANCER RES, V22, P459
[10]   Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy [J].
Overgaard, M ;
Hansen, PS ;
Overgaard, J ;
Rose, C ;
Andersson, M ;
Bach, F ;
Kjaer, M ;
Gadeberg, CC ;
Mouridsen, HT ;
Jensen, MB ;
Zedeler, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :949-955